| |
 |
Fen-Phen
In 1997 the FDA asked American Home Products (AHP), the makers of Pondimin (Fenfluramine) and Redux (Dexfenfluramine), to withdraw it's popular anti-obesity combination Fen-Phen drug from the market. AHP manufactured fenfluramine under the brand name Pondimin and AHP's subsidiary, Wyeth-Ayerst Laboratories, manufactured dexfenfluramine under the name Redux. Medical studies have linked Pondimin and Redux to heart valve disease...MORE >>
Featured Articles on Fen-Phen
- May 17, 2004 - Texas judge affirms $1 billion award in diet drug case
- April 20, 2004 - Majority Counsel Says Fen-Phen Trust Fund is Bust
- November 24, 2003 - 'Fen-Phen' Trust Seeks to Toss Claims
- May 21, 2003 - Thousands of Fen-Phen Patients Opt-Out of Class Action
- March 2, 2002 - American Home Products Settles Drug Suit
- September 17, 2001 - AHP still pursued by Fen-Phen specter
- September 10, 2001 - Lawsuits on the rise as Fen-Phen/Redux withdrawal approaches 4-year anniversary; cases against diet drug manufacturer could double
- July1, 2001 - Bitter Pill: The Fen-Phen story
- January 3, 2001 - Woman settles Fen-Phen case
- August 29, 2000 - Judge oks deal on drug linked to heart valve disease
Browse Books About Fen-Phen Drug Litigation
5.Personal
Injury and Product Liability...
6.Psychology
in Product Liability and...
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
|
|
